Certain Common Stock of Adagio Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-FEB-2022. These Common Stock will be under lockup for 181 days starting from 5-AUG-2021 to 2-FEB-2022.

Details:
The executive officers, directors and substantially all of the holders of common stock outstanding on the date of this prospectus have entered into lock-up agreements with the underwriters or otherwise agreed, subject to certain exceptions, that they will not, directly or indirectly, offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale, or otherwise dispose of or hedge any of shares of common stock, any options or warrants to purchase shares of common stock, or any securities convertible into, or exchangeable for or that represent the right to receive shares of common stock, without the prior written consent of Morgan Stanley & Co. LLC and Jefferies LLC for a period of 180 days from the date of this prospectus.